Hair loss is a critical issue among men and women across the world. Men, owing to Androgenetic Alopecia or common male pattern baldness (MPB), have been suffering from hair loss for long. However, recently, women are also experiencing increased hair loss, due to external factors, such as environmental pollution and chemicals. According to the American Academy of Dermatology, 40% of women have visible hair loss by the age of 40. In most cases, hair loss in women affects their self-image and emotional well-being. As a result, the American Hair Loss Association recognized hair loss in women to be a serious life-altering condition that cannot be ignored anymore. Hormone imbalance and diseases are the primary reasons for hair loss. In such cases, hair loss is often naturally reversed, as the subject undergoes unpredictable patterns of growth and shedding.

North America is having a huge market for hair loss medication and is going to dominate the market over the period of forecast followed by Europe. According to American Hair Loss Association more than 80 million men and women are suffering from hair loss problems in the US alone. There are many positive initiatives taken by organizations such as NAAF and the American Hair Loss Association. According to the Eurostat, the population in the European Union between 15-60 years is expected to decline by 2060, while the population above 60 years is expected to grow from 18% to 30%. Similarly, in America, the ageing population is forecasted to be doubled by 2060 to reach 98 million. Increased hair loss problems due to ageing have strongly affected the market growth.